What are Labcorp Holdings's total assets?

Labcorp Holdings (LH) holds $19.1B in total assets, up 8.4% year over year.

How much debt does Labcorp Holdings have?

Labcorp Holdings carries $7.2B in total debt against $8.7B of shareholders' equity, a debt-to-equity ratio of 0.83.

How much cash does Labcorp Holdings have?

Labcorp Holdings holds $981.1M in cash and equivalents.

Can Labcorp Holdings cover its short-term obligations?

Its current ratio is 1.73 — current assets exceed current liabilities.

Where does Labcorp Holdings's balance sheet data come from?

Every line is extracted from Labcorp Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Labcorp Holdings LH Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$532.3M-65.0%	$1.52B+183%	$536.8M+24.8%	$430M-70.8%
Accounts receivable, net	$2.1B+8.2%	$1.94B+1.6%	$1.91B+7.2%	$1.79B-21.0%
Inventories	$534.7M+8.4%	$493.2M+3.9%	$474.6M+0.8%	$470.6M+17.2%
Prepaid expenses and other current assets	$692.8M-0.7%	$697.6M+6.5%	$655.3M+7.4%	$610.4M+27.7%
Contract assets	$156.9M+2.6%	$152.9M-17.5%	$185.4M-12.5%	$211.8M-70.5%
Total current assets	$4.02B-16.4%	$4.81B+27.6%	$3.77B-18.6%	$4.63B-13.2%
Property and equipment, net	$3.08B+1.2%	$3.05B+4.6%	$2.91B+4.2%	$2.79B-0.8%
Accumulated depreciation	$2.29B+17.8%	$1.94B+13.3%	$1.72B+16.8%	$1.47B-12.9%
Goodwill	$6.79B+6.6%	$6.37B+3.7%	$6.14B+0.3%	$6.12B+4.0%
Intangible assets, net	$3.04B-13.0%	$3.49B+4.4%	$3.34B+7.0%	$3.12B-16.4%
Deferred tax assets	-$97.6M-586%	$20.1M—	——	-$38.4M+52.2%
Other non-current assets	$751.3M+15.2%	$652.2M+21.6%	$536.5M+41.8%	$378.4M-18.2%
Equity method investments	$153.9M+844%	$16.3M-39.4%	$26.9M-59.1%	$65.7M+7.9%
Long-term investments	$201.9M—	——	——	——
Total assets	$18.39B+0.1%	$18.38B+9.9%	$16.73B-17.0%	$20.16B-1.1%
Accounts payable	$840.8M-4.0%	$875.8M+5.8%	$827.5M-2.9%	$852.2M+37.2%
Accrued expenses	$847.8M-2.7%	$871.2M+8.4%	$804M+2.2%	$787M-43.9%
Deferred revenue	$439.1M+12.0%	$392.2M-7.0%	$421.7M+35.8%	$310.6M-44.4%
Current portion of long-term debt	$500.1M-50.0%	$1B+15,530%	$6.4M+6.7%	$6M-42.9%
Operating lease liabilities, current	$191.1M+3.5%	$184.6M+11.3%	$165.8M+1.2%	$163.8M-12.4%
Finance Lease Liability, Current	$4.6M-24.6%	$6.1M-4.7%	$6.4M+6.7%	$6M-42.9%
Total current liabilities	$2.82B-15.2%	$3.33B+3.3%	$3.23B+4.8%	$3.08B+10.6%
Long-term debt	$5.08B-4.6%	$5.33B+31.5%	$4.05B-19.5%	$5.04B-7.0%
Operating lease liabilities, non-current	$682.6M+0.9%	$676.3M+4.2%	$648.9M-0.6%	$652.9M+1.6%
Finance lease liabilities	$63M-15.2%	$74.3M-5.5%	$78.6M-6.0%	$83.6M-1.2%
Other non-current liabilities	$647.8M+25.2%	$517.4M+26.4%	$409.3M+2.0%	$401.1M-0.2%
Total liabilities	$9.76B-5.4%	$10.31B+16.7%	$8.83B-12.0%	$10.04B-0.5%
Common stock	7.5M-1.3%	7.6M-1.3%	7.7M-4.9%	8.1M-4.7%
Additional paid-in capital	$0-100%	$2.8M-92.7%	$38.4M—	$0—
Retained earnings	$8.64B+4.1%	$8.3B+5.3%	$7.89B-25.5%	$10.58B+1.2%
Accumulated other comprehensive income (loss)	-$27.6M+89.4%	-$261.6M-341%	-$59.3M+88.0%	-$493.2M-157%
Total stockholders' equity	$8.62B+7.0%	$8.05B+2.3%	$7.88B-22.0%	$10.1B-1.7%
Total liabilities and stockholders' equity	$18.39B+0.1%	$18.38B+9.9%	$16.73B-17.0%	$20.16B-1.1%
Allowance for Doubtful Accounts	$36.4M-18.6%	$44.7M+36.7%	$32.7M+6.5%	$30.7M+42.8%
Allowance for Doubtful Accounts Receivable (Current)	$36.4M-18.6%	$44.7M+36.7%	$32.7M+6.5%	$30.7M+42.8%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	$532.3M-65.0%	$1.52B+183%	$536.8M+24.8%	$430M-70.8%
Derivative Assets - Not Designated as Hedging Instruments	$274M+92.0%	$142.7M+30.9%	$109M+139%	$45.7M+39.3%
Unbilled Revenue	$156.9M+2.6%	$152.9M-17.5%	$185.4M-12.5%	$211.8M-70.5%
Deferred Tax Assets and Other Non-Current Assets	$751.3M+15.2%	$652.2M+21.6%	$536.5M+41.8%	$378.4M-18.2%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)	——	——	——	——
Finite Lived Intangible Assets - Gross	$5.33B+9.3%	$4.88B—	——	——
Intangible Assets Gross (Excluding Goodwill)	$5.89B+8.3%	$5.43B+7.4%	$5.06B+10.1%	$4.59B-15.3%
Intangible assets — net	$3.04B+3.6%	$2.93B—	——	——
Other intangible assets—net	$3.6B+3.1%	$3.49B+4.4%	$3.34B+7.0%	$3.12B-16.4%
Investments	$201.9M—	——	——	——
Investments	$153.9M+844%	$16.3M-39.4%	$26.9M-59.1%	$65.7M+7.9%
Other non-current assets	$751.3M+15.2%	$652.2M+21.6%	$536.5M+41.8%	$378.4M-18.2%
Software and Technology Licenses, Net	$751.3M+15.2%	$652.2M+21.6%	$536.5M+41.8%	$378.4M-18.2%
Other Commercial Liabilities	$847.8M-2.7%	$871.2M+8.4%	$804M+2.2%	$787M-43.9%
Commercial Paper Outstanding	——	——	——	——
Accrued Liabilities, Current	$847.8M-2.7%	$871.2M+8.4%	$804M+2.2%	$787M-43.9%
Deferred income	$439.1M+12.0%	$392.2M-7.0%	$421.7M+35.8%	$310.6M-44.4%
Notes Payable Current	$300K-25.0%	$400K-63.6%	$1.1M-35.3%	$1.7M+13.3%
Notes Payable	$300K-25.0%	$400K-63.6%	$1.1M-35.3%	$1.7M+13.3%
Contingent Consideration Liability (Non-Current)	$50M—	——	——	——
Unrecognized Tax Benefits	$454.5M+18.6%	$383.1M—	——	——
Convertible Preferred Stock Authorized Shares	——	——	——	——
Convertible Preferred Stock Outstanding Shares	0—	——	——	——
Additional paid-in capital	$0-100%	$2.8M-92.7%	$38.4M—	$0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$7.5M-1.3%	$7.6M-1.3%	$7.7M-4.9%	$8.1M-4.7%
Preferred Stock Par Value Per Share	——	——	——	——
Share Repurchase Authorization Limit	——	——	——	——
Share Repurchase Program - Amount Remaining	——	——	——	——
Line of Credit Maximum Borrowing Capacity	——	——	——	——
2.70% senior notes due 2031	$447.3M+5.7%	$423.2M-1.7%	$430.4M—	——
3.60% senior notes due 2027	$600M0.0%	$600M0.0%	$600M0.0%	$600M0.0%
4.70% senior notes due 2045	$900M0.0%	$900M0.0%	$900M0.0%	$900M0.0%
Accounts Receivable, Allowance for Credit Loss	$36.4M-18.6%	$44.7M+36.7%	$32.7M+6.5%	$30.7M+42.8%
Allowance for Credit Loss	$43.5M-16.8%	$52.3M+27.9%	$40.9M-2.4%	$41.9M+16.1%
Business Combination, Contingent Consideration, Liability	$50M—	——	——	——
Cash and cash equivalents, end of period	$532.3M-65.0%	$1.52B+183%	$536.8M+24.8%	$430M-70.8%
Insurance contracts	$99.6M-2.4%	$102.1M+7.0%	$95.4M-5.3%	$100.7M-5.4%
Common stock, shares authorized (in shares)	——	——	——	——
Common Stock, Shares, Outstanding	$82.2M-1.4%	$83.4M-0.6%	$83.9M-4.9%	$88.2M-5.3%
Credit Facility, Maximum Swing Line Borrowings	——	——	——	——
Credit Facility Option to Increase	——	——	——	——
Deferred compensation plan assets	——	$35.7M—	——	——
Deferred Income Taxes and Other Tax Liabilities, Noncurrent	$454.5M+18.6%	$383.1M—	——	——
Derivative, Interest Rate Swap	——	——	——	——
Fair Value Hedges At Fair Value Net	$52.7M-31.4%	$76.8M+10.3%	$69.6M-12.7%	$79.7M+2,648%
Noncontrolling interest put	$16.9M+18.2%	$14.3M-7.7%	$15.5M+3.3%	$15M-8.0%
Deferred compensation liability	$150.5M+13.6%	$132.5M+23.4%	$107.4M+10.8%	$96.9M-7.2%
Current maturities of long-term debt	$4.6M-24.6%	$6.1M-4.7%	$6.4M+6.7%	$6M-42.9%
Finite-Lived Intangible Assets, Accumulated Amortization	$2.29B+17.8%	$1.94B+13.3%	$1.72B+16.8%	$1.47B-12.9%
2028	——	——	——	——
2030	——	——	——	——
2031	——	——	——	——
2027	——	——	——	——
2029	——	——	——	——
Finite Lived Intangible Assets Amortization Expense After Year Five	——	——	——	——
Gross Carrying Amount	$5.33B+9.3%	$4.88B—	——	——
Goodwill Impairment, Cumulative	$648.5M0.0%	$648.5M—	——	——
Indefinite- lived intangible impairment	$5.89B+8.3%	$5.43B+7.4%	$5.06B+10.1%	$4.59B-15.3%
Letters of Credit Outstanding, Amount	——	——	——	——
Line Of Credit Facility Current Borrowing Capacity	——	——	——	——
Committed Revolving Credit Facilities	——	——	——	——
Long term debt issuance costs	$37.7M-10.9%	$42.3M+60.8%	$26.3M-22.2%	$33.8M-17.6%
Noncontrolling interest	$16.9M+18.2%	$14.3M-7.7%	$15.5M-18.0%	$18.9M-8.3%
Preferred Stock, Par or Stated Value Per Share	——	——	——	——
Preferred Stock, Shares Authorized	——	——	——	——
Preferred Stock, Shares Outstanding	$0—	——	——	——
Fair market value of senior notes	$4.96B-13.9%	$5.76B+18.8%	$4.85B-2.5%	$4.97B-14.8%
Short term debt issuance costs	$200K+100%	$100K-92.3%	$1.3M+225%	$400K—
Share Repurchase Program, Remaining Authorized, Amount	——	——	——	——
2026 Term Loan	$0—	——	——	——
Unbilled balances	$156.9M+2.6%	$152.9M-17.5%	$185.4M-12.5%	$211.8M-70.5%
Unbilled Services, Allowance for Credit Loss	$7.1M-6.6%	$7.6M+1.3%	$7.5M-28.6%	$10.5M-24.5%
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two	——	——	——	——
Unrecorded Unconditional Purchase Obligation	——	——	——	——
Purchase commitments, Due in 2027	——	——	——	——
Unrecorded Unconditional Purchase Obligation	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Labcorp Holdings.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Labcorp Holdings's total assets?: Labcorp Holdings (LH) holds $19.1B in total assets, up 8.4% year over year.
How much debt does Labcorp Holdings have?: Labcorp Holdings carries $7.2B in total debt against $8.7B of shareholders' equity, a debt-to-equity ratio of 0.83.
How much cash does Labcorp Holdings have?: Labcorp Holdings holds $981.1M in cash and equivalents.
Can Labcorp Holdings cover its short-term obligations?: Its current ratio is 1.73 — current assets exceed current liabilities.
Where does Labcorp Holdings's balance sheet data come from?: Every line is extracted from Labcorp Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.